Breakthrough trial aims to free kidney patients from lifelong drugs
NCT ID NCT04803058
Summary
This study is testing a new drug combination to see if it can safely train a kidney transplant patient's immune system to accept the donated organ without needing lifelong anti-rejection medications. It involves 18 adult patients who received a kidney from a living donor. The approach uses a special antibody drug along with a mild chemotherapy and an infusion of cells from the donor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Samsung Medical University
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.